Gastroprotective and Antioxidant Effects of Opipramol on Indomethacin-induced Ulcers in Rats

DOI Web Site Web Site 参考文献45件
  • DURSUN Hakan
    Ataturk University, Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology
  • ALBAYRAK Fatih
    Ataturk University, Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology
  • BILICI Mehmet
    Ataturk University, Faculty of Medicine, Department of Internal Medicine
  • KOC Feride
    Ataturk University, Faculty of Veterinary Medicine, Department of Pharmacology and Toxicology
  • ALP Hamit Hakan
    Ataturk University, Faculty of Medicine, Department of Biochemistry
  • CANDAR Tuba
    Ataturk University, Faculty of Medicine, Department of Biochemistry
  • KUKULA Osman
    Samsun Mehmet Aydin Hospital, Pharmacology

この論文をさがす

抄録

  Tricyclic antidepressants are particularly useful in the treatment of endogenous depression. Since the 1950s, tricyclic antidepressants (TCAs) have also been used for the treatment of gastric ulcer disease. Many TCAs have been evaluated for their antiulcer effects, but there are presently no data in the literature specifically concerning the antidepressant opipramol. This study aimed to investigate the antiulcer effects of opipramol and to determine its potential relationship with oxidant and antioxidant systems. The antiulcer activities of 25, 50 and 100 mg/kg opipramol have been investigated on indomethacin-induced ulcers in rats. Compared with a control group (indomethacin alone), opipramol decreased indomethacin-induced ulcers significantly at all doses used (52%, 71% and 76% respectively). Opipramol also significantly increased the glutathione (GSH), superoxide dismutase (SOD) and nitric oxide (NO) levels in the stomach tissue, all of which were decreased in the control group given only indomethacin. All doses of opipramol also significantly decreased myeloperoxidase (MPO), malondialdehyde (MDA) and catalase (CAT) levels in stomach tissue compared to the control. In conclusion, the activation of enzymatic and non-enzymatic antioxidant mechanisms, as well as the inhibition of some toxic oxidant mechanisms, appear to play a role in the antiulcer effect of opipramol. This new indication for opipramol prompts a rethinking about the possible clinical application of opipramol, particularly for peptic ulcer patients also presenting depression.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 129 (7), 861-869, 2009-07-01

    公益社団法人 日本薬学会

参考文献 (45)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ